Gildan Activewear Inc. (GIL) Stock Price & Analysis
Gildan Activewear Inc. (GIL) closed at USD 41.03 on Thursday, October 22, 2026, up 1.79% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 40.31; the Oct 22, 2026 session ranged USD 39.86–41.2 on volume of 2,204,430 shares. Market capitalization is $7.60B, with a 52-week range of USD 39.81–73.7 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 10:12 UTC.
Also available as compact Markdown for AI agents: nexqual.com/GIL.md
Key facts (GIL)
- 1 of 80 tracked superinvestors hold GIL (13F, Q2 2026): 0 new, 0 added, 0 reduced, 1 unchanged.
- Analysts: Buy (mean 1.67 on a 1–5 scale) (12 analysts), mean target USD 73 (range 54–95).
- Total return with dividends: 1Y -31.6% vs S&P 500 +14.9%; 5Y +23.1% vs S&P 500 +80.3%.
- Next earnings: 2026-11-05, EPS estimate USD 1.59, revenue estimate $1.62B.
Superinvestors (SEC 13F-HR, Q2 2026) (GIL)
1 of 80 tracked investors hold GIL. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Bryan Lawrence | Oakcliff Capital | 13.10% | $35.2M | Unchanged |
Analysts (GIL)
Consensus Buy (mean 1.67 on a 1–5 scale), 12 analysts; mean target USD 73 (low 54, high 95).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-20 | RBC Capital | Target lowered | Outperform | $82 → $70 |
| 2026-10-15 | UBS | Target lowered | Buy | $111 → $71 |
| 2026-09-24 | TD Securities | Target lowered | Buy | $80 → $54 |
| 2026-07-31 | UBS | Target raised | Buy | $110 → $111 |
| 2026-07-31 | RBC Capital | Target raised | Outperform | $78 → $82 |
| 2026-07-31 | Scotiabank | Target raised | Sector Outperform | $65 → $67 |
Total return (dividends reinvested) (GIL)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -31.6% | +23.1% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -31.6% | +4.2% |
| Volatility (annualized) | 42.2% | 31.1% |
| Max drawdown | -43.7% (Feb 2026→Oct 2026) | -42.8% (Feb 2026→Oct 2026) |
GIL analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $1.59 | $1.36 | +17.2% | $1.62B | 10 |
| Next quarter (ends Dec 2026) | $1.32 | $1.38 | -4.3% | $1.61B | 8 |
| Current fiscal year (ends Dec 2026) | $4.61 | $4.28 | +7.7% | $5.99B | 12 |
| Next fiscal year (ends Dec 2027) | $5.33 | $5.36 | -0.7% | $6.20B | 12 |
Key Statistics (as of October 23, 2026 at 10:12 UTC)
| Price | USD 41.03 |
|---|---|
| Change | ▲ 1.79% (up) |
| Previous Close | USD 40.31 |
| Open | USD 39.99 |
| Day Range | USD 39.86 – 41.2 |
| 52-Week Range | USD 39.81 – 73.7 |
| Volume | 2,204,430 shares |
| Market Cap | $7.60B |
| Exchange | NYQ |
Technical Analysis (GIL)
Nexqual's technical model rates GIL "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 10:12 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 33.18 (neutral) |
| vs SMA50 | Below (USD 47.34) |
| MACD | -1.68 (negative) |
Analyst Ratings (GIL)
Wall Street analysts rate GIL "Buy" based on 12 analysts, with a mean price target of USD 73 (range USD 54–95), per Nexqual as of October 23, 2026 at 10:12 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 12 |
| Mean Target | USD 73 |
| High Target | USD 95 |
| Low Target | USD 54 |
| Buy / Hold / Sell | 11 / 1 / 0 |
Earnings (GIL)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD 1.59 |
| Revenue Estimate | $1.62B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.28 vs est 1.12 ▲ beat |
| 2026-03-31 | USD 0.43 vs est 0.35 ▲ beat |
| 2025-12-31 | USD 0.96 vs est 0.95 ▲ beat |
| 2025-09-30 | USD 1 vs est 0.98 ▲ beat |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Financials & Fundamentals (GIL)
| Total Revenue | $4.74B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +72.30% |
| Gross Margin | +33.44% |
| Operating Margin | +22.26% |
| Profit Margin | +1.28% |
| ROE | +8.68% |
| Debt / Equity | 1.48 |
| Current Ratio | 1.93 |
| Total Cash | $386.70M |
| Total Debt | $4.93B |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Financial Health Score (GIL)
Nexqual rates Gildan Activewear Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 10:12 UTC.
| Growth | Solid — Revenue +11% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 33%, operating 22% (last 12 months) |
| Balance Sheet | Mixed — $387M cash vs $4.93B debt |
| Cash Flow | Solid — Operating cash flow $628M (TTM) |
| Efficiency | Mixed — ROE 9%, ROA 8.5% |
Ownership (GIL)
| Insider Ownership | +0.58% |
|---|---|
| Institutional Ownership | +104.75% |
| Shares Outstanding | 185.19M |
| Float | 183.13M |
| Short % of Float | +7.76% |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Leadership (GIL)
Gildan Activewear Inc. is led by Glenn J. Chamandy, Co-Founder, President, CEO & Director, per Nexqual as of October 23, 2026 at 10:12 UTC.
| Co-Founder, President, CEO & Director | Glenn J. Chamandy |
|---|---|
| Executive VP & CFO | Luca Barile |
| President of Manufacturing | Benito A. Masi |
| Director of Corporate Communications & Corporate Marketing | Genevieve Gosselin |
Major Backers & Investors (GIL)
Notable institutional backers of Gildan Activewear Inc. include Caisse De Depot Et Placement Du Quebec, Jupiter Topco LLC, JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund, according to Nexqual as of October 23, 2026 at 10:12 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Caisse De Depot Et Placement Du Quebec | 6.31% |
| Jupiter Topco LLC | 6% |
| JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund | 3.72% |
| Royal Bank of Canada | 3.69% |
| Mackenzie Financial Corporation | 3.64% |
| 1832 Asset Management L.P. | 3.45% |
| Bank of Montreal /CAN/ | 3.16% |
| Cooke & Bieler LP | 2.81% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.76% |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LEVI | Levi Strauss & Co | USD 21.36 | ▲ 2.05% |
| VFC | V.F. Corporation | USD 17.48 | ▲ 1.92% |
| KTB | Kontoor Brands, Inc. | USD 77.78 | ▲ 3.61% |
| PVH | PVH Corp. | USD 84.26 | ▲ 0.8% |
| ZGN | Ermenegildo Zegna N.V. | USD 13.85 | ▲ 7.2% |
| FIGS | FIGS, Inc. | USD 20.46 | ▲ 2.4% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:12 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt